为了更好地了解患者的期望:ONCOPREMs-1研究 - - 定性研究
Loubna Diouri1,2, Fiona Ecarnot3,4, Sophie Berjot5
1IRMAIC, Université Reims Champagne Ardenne, 51 Rue Cognacq Jay, 51100, Reims, France. Loubna.diouri@reims.unicancer.fr.
Aging clinical and experimental research
|August 26, 2025
概括
这项研究探讨了癌症患者的经历, 发现他们的护理途径普遍符合预期. 患者希望对护理人员提供更多支持, 突出了瘤治疗改善的关键领域.
科学领域:
- 癌症学
- 患者体验研究
- 质量健康研究
背景情况:
- 作为OncoPREMs研究的一部分,开发了一种患者体验评估工具.
- 探索患者从最初的症状到生存情况的看法.
- 专注于癌症患者的生活经验.
研究的目的:
- 了解患者在整个癌症护理过程中的期望和经验.
- 确定患者对瘤治疗的看法中的关键主题.
- 帮助开发以患者为中心的瘤护理工具.
主要方法:
- 使用半结构面试进行定性研究.
- 在法国对28名癌症患者 (14名男性,14名女性) 进行了研究.
- 对面试数据进行主题分析.
主要成果:
- 确定了关键主题:诊断,治疗和癌症后的生存.
- 常见的癌症包括乳腺癌,消化癌和泌尿癌.
- 患者的经验通常与预期一致.
结论:
- 癌症治疗途径大多满足患者的需求和期望.
- 患者强调需要加强护理人员的支持和指导.
- 结果为瘤学患者和护理人员的支持提供了改善的信息.
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
174
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
174
Guidelines for Writing Outcome
3.0K
When developing expected outcomes for a patient care plan, the nurse should adhere to the following recommendations:
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
3.0K
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Preclinical Development: Overview
4.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K
Clinical Trials
8.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
8.1K
Cancer Survival Analysis
453
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
453


